Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rab K Prinjha

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
The Journal of Experimental Medicine|June 24, 2018
Drawing on disorder: How viruses use histone mimicry to their advantageAlexander Tarakhovsky, Rab K Prinjha
Epigenomics|December 8, 2016
Immune disease-associated variants in gene enhancers point to BET epigenetic mechanisms for therapeutic interventionDavid F Tough, Rab K Prinjha
Clinical Medicine (London, England)|December 5, 2015
Epigenetic mechanisms and drug discovery in rheumatologyDavid F Tough, Rab K Prinjha, Paul P Tak
Trends in Immunology|December 10, 2019
Epigenetic Regulation of T Cell Memory: Recalling Therapeutic ImplicationsDavid F Tough, Inma Rioja, Louise K Modis, et al.
Nature Reviews. Drug Discovery|November 4, 2016
Epigenetic drug discovery: breaking through the immune barrierDavid F Tough, Paul P Tak, Alexander Tarakhovsky, et al.
Cold Spring Harbor Symposia on Quantitative Biology|April 16, 2014
The "histone mimicry" by pathogensUwe Schaefer, Jessica S Y Ho, Rab K Prinjha, et al.
Current Opinion in Chemical Biology|June 14, 2016
Clinical progress and pharmacology of small molecule bromodomain inhibitorsNatalie H Theodoulou, Nicholas Co Tomkinson, Rab K Prinjha, et al.
Future Medicinal Chemistry|August 23, 2017
Small molecules and their role in effective preclinical target validationMichael A Clegg, Nicholas Co Tomkinson, Rab K Prinjha, et al.
Chemmedchem|January 10, 2019
Advancements in the Development of non-BET Bromodomain Chemical ProbesMichael A Clegg, Nicholas C O Tomkinson, Rab K Prinjha, et al.
Chemmedchem|January 11, 2016
Progress in the Development of non-BET Bromodomain Chemical ProbesNatalie H Theodoulou, Nicholas C O Tomkinson, Rab K Prinjha, et al.
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Experimental Medicine|June 24, 2018
Drawing on disorder: How viruses use histone mimicry to their advantageAlexander Tarakhovsky, Rab K Prinjha
Epigenomics|December 8, 2016
Immune disease-associated variants in gene enhancers point to BET epigenetic mechanisms for therapeutic interventionDavid F Tough, Rab K Prinjha
Clinical Medicine (London, England)|December 5, 2015
Epigenetic mechanisms and drug discovery in rheumatologyDavid F Tough, Rab K Prinjha, Paul P Tak
Trends in Immunology|December 10, 2019
Epigenetic Regulation of T Cell Memory: Recalling Therapeutic ImplicationsDavid F Tough, Inma Rioja, Louise K Modis, et al.
Nature Reviews. Drug Discovery|November 4, 2016
Epigenetic drug discovery: breaking through the immune barrierDavid F Tough, Paul P Tak, Alexander Tarakhovsky, et al.
Cold Spring Harbor Symposia on Quantitative Biology|April 16, 2014
The "histone mimicry" by pathogensUwe Schaefer, Jessica S Y Ho, Rab K Prinjha, et al.
Current Opinion in Chemical Biology|June 14, 2016
Clinical progress and pharmacology of small molecule bromodomain inhibitorsNatalie H Theodoulou, Nicholas Co Tomkinson, Rab K Prinjha, et al.
Future Medicinal Chemistry|August 23, 2017
Small molecules and their role in effective preclinical target validationMichael A Clegg, Nicholas Co Tomkinson, Rab K Prinjha, et al.
Chemmedchem|January 10, 2019
Advancements in the Development of non-BET Bromodomain Chemical ProbesMichael A Clegg, Nicholas C O Tomkinson, Rab K Prinjha, et al.
Chemmedchem|January 11, 2016
Progress in the Development of non-BET Bromodomain Chemical ProbesNatalie H Theodoulou, Nicholas C O Tomkinson, Rab K Prinjha, et al.
Pageof 13